Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Jun ‘22 |
|
|---|---|---|---|---|---|
| $1.56M | $1.57M | $15K | 98.1% |
|
|
| $1.56M | $1.75M | $196K | 31.2% |
|
|
| $1.54M | $1.54M | $0 | 17.4% |
|
|
154
Zentalis Pharmaceuticals
ZNTL
$186M
| $1.52M | $1.53M | $17K | 89.8% |
|
| $1.5M | $1.82M | $321K | 30.5% |
|
|
| $1.49M | $1.77M | $273K | 67.3% |
|
|
| $1.48M | $2.93M | $1.45M | 84% |
|
|
| $1.47M | $1.74M | $269K | 92.2% |
|
|
| $1.44M | $1.59M | $151K | 54.9% |
|
|
| $1.44M | $2.13M | $693K | 80.5% |
|
|
161
Protalix BioTherapeutics
PLX
$165M
| $1.41M | $1.63M | $218K | 88.1% |
|
| $1.38M | $3.59M | $2.21M | 88.9% |
|
|
| $1.3M | $1.31M | $8K | 83.7% |
|
|
| $1.29M | $1.77M | $488K | 35.4% |
|
|
| $1.28M | $1.73M | $449K | 56.4% |
|
|
| $1.28M | $1.48M | $200K | 70.9% |
|
|
| $1.26M | $1.5M | $233K | 88.1% |
|
|
| $1.26M | $1.26M | $0 | 70.7% |
|
|
| $1.23M | $1.43M | $202K | 42.5% |
|
|
| $1.22M | $2.82M | $1.59M | 99.8% |
|
|
| $1.22M | $2.05M | $829K | 93.1% |
|
|
| $1.19M | $1.66M | $463K | 94.6% |
|
|
| $1.19M | $4.77M | $3.58M | 98.5% |
|
|
| $1.19M | $3.27M | $2.09M | 96.1% |
|
|
| $1.18M | $1.24M | $58K | 75.9% |
|